
Bayern Kapital
Description
Bayern Kapital is a prominent venture capital firm established in 1995 by the Free State of Bavaria, with its headquarters in Landshut, Germany. Its core mission is to bolster Bavaria's position as a leading high-tech location by providing crucial financing to innovative companies. The firm focuses on supporting Bavarian-based startups and growth-stage companies across various sectors, including life sciences, software, cleantech, and industrial technologies. Their investment scope covers critical phases such as research and development, market launch of new products, and product diversification, aiming to foster sustainable growth and job creation within the region.
As a state-owned venture capital company, Bayern Kapital plays a significant role in the Bavarian innovation ecosystem, often acting as a co-investor alongside private venture capital funds and business angels. This collaborative approach helps de-risk investments for private partners while ensuring promising Bavarian enterprises receive the necessary capital. The firm manages several funds, including the "Wachstumsfonds Bayern" (Bavarian Growth Fund), and has built a substantial portfolio over its nearly three decades of operation. Bayern Kapital typically provides investments ranging from EUR 0.25 million to EUR 10 million per company, tailored to the specific needs and stage of the recipient.
To date, Bayern Kapital has managed funds exceeding EUR 700 million, which has been instrumental in financing over 300 companies across Bavaria. These investments have not only propelled technological advancements but have also significantly contributed to economic development, helping to create or secure more than 8,000 jobs within the region. The firm's long-term commitment and strategic funding initiatives underscore its importance in nurturing a vibrant startup landscape and driving innovation from early-stage concepts through to successful market penetration.
Investor Profile
Bayern Kapital has backed more than 250 startups, with 28 new investments in the last 12 months alone. The firm has led 35 rounds, about 14% of its total and boasts 27 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in Germany, United States, Finland.
- Strong thematic focus on Software, Health Care, SaaS.
- Led 5 rounds in the past year.
- Typical check size: $270K – $10.8M.
Stage Focus
- Seed (27%)
- Series A (24%)
- Series Unknown (22%)
- Series B (14%)
- Series C (6%)
- Pre Seed (4%)
- Series H (1%)
- Series F (1%)
- Convertible Note (1%)
Country Focus
- Germany (95%)
- United States (4%)
Industry Focus
- Software
- Health Care
- Saas
- Biotechnology
- Information Technology
- Manufacturing
- Medical
- Artificial Intelligence (Ai)
- Medical Device
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.